PortfoliosLab logoPortfoliosLab logo
sheep special
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


VKTX 16.67%NVO 16.67%NVAX 16.67%BNTX 16.67%PFE 16.67%MRNA 16.67%EquityEquity

S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in sheep special, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Oct 10, 2019, corresponding to the inception date of BNTX

Returns By Period


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.11%-3.43%-3.84%-1.98%16.08%16.86%10.37%12.29%
Portfolio
sheep special
0.50%-2.14%11.91%6.67%21.09%7.47%10.12%
VKTX
Viking Therapeutics, Inc.
5.58%8.99%-1.08%24.82%35.51%25.58%40.84%37.04%
NVO
Novo Nordisk A/S
1.37%4.40%-24.78%-34.84%-43.28%-20.60%3.97%5.03%
NVAX
Novavax, Inc.
-3.99%-18.86%14.58%-19.37%28.76%1.33%-47.10%-23.09%
BNTX
BioNTech SE
1.97%-9.51%-4.22%-12.75%-2.29%-11.04%-3.91%
PFE
Pfizer Inc.
-0.81%6.55%15.64%8.20%22.98%-6.37%0.03%4.18%
MRNA
Moderna, Inc.
-1.66%-1.26%66.84%73.42%77.49%-32.43%-17.98%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Oct 11, 2019, sheep special's average daily return is +0.19%, while the average monthly return is +4.09%. At this rate, your investment would double in approximately 1.4 years.

Historically, 56% of months were positive and 44% were negative. The best month was Feb 2024 with a return of +46.6%, while the worst month was Jan 2022 at -23.4%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 6 months.

On a daily basis, sheep special closed higher 50% of trading days. The best single day was Feb 27, 2024 with a return of +35.4%, while the worst single day was Mar 9, 2020 at -13.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202617.85%3.19%-8.42%0.48%11.91%
2025-1.25%-6.39%-16.06%4.95%-1.34%-0.33%0.38%-2.37%3.81%6.35%-3.05%-0.75%-16.64%
20241.76%46.60%6.17%-3.41%45.35%-11.49%3.40%-3.55%2.56%-6.62%-10.97%-9.47%51.52%
2023-2.86%-4.73%11.15%2.62%-1.09%-7.52%1.66%0.08%-9.01%-10.35%3.74%12.60%-6.39%
2022-23.41%-7.93%4.22%-17.09%6.94%1.58%6.15%-13.99%-12.77%19.59%4.98%22.48%-18.96%
202138.38%-3.90%-8.79%26.55%-5.28%16.02%17.42%9.11%-7.14%-4.67%12.30%-13.61%85.61%

Benchmark Metrics

sheep special has an annualized alpha of 43.97%, beta of 0.83, and R² of 0.12 versus S&P 500 Index. Calculated based on daily prices since October 11, 2019.

  • This portfolio captured 167.94% of S&P 500 Index gains but only 52.80% of its losses — a favorable profile for investors.
  • R² of 0.12 means this portfolio moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
43.97%
Beta
0.83
0.12
Upside Capture
167.94%
Downside Capture
52.80%

Expense Ratio

sheep special has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

sheep special ranks 13 for risk / return — in the bottom 13% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


sheep special Risk / Return Rank: 1313
Overall Rank
sheep special Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
sheep special Sortino Ratio Rank: 1111
Sortino Ratio Rank
sheep special Omega Ratio Rank: 1010
Omega Ratio Rank
sheep special Calmar Ratio Rank: 2222
Calmar Ratio Rank
sheep special Martin Ratio Rank: 1313
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.52

0.88

-0.37

Sortino ratio

Return per unit of downside risk

0.98

1.37

-0.38

Omega ratio

Gain probability vs. loss probability

1.12

1.21

-0.09

Calmar ratio

Return relative to maximum drawdown

1.32

1.39

-0.07

Martin ratio

Return relative to average drawdown

2.59

6.43

-3.85


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
VKTX
Viking Therapeutics, Inc.
590.461.111.171.012.23
NVO
Novo Nordisk A/S
11-0.80-0.970.87-0.78-1.35
NVAX
Novavax, Inc.
560.381.161.130.791.66
BNTX
BioNTech SE
38-0.050.291.040.030.06
PFE
Pfizer Inc.
680.871.381.171.894.26
MRNA
Moderna, Inc.
751.181.931.232.294.71

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

sheep special Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

  • 1-Year: 0.52
  • 5-Year: 0.23
  • All Time: 0.91

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.98 to 1.66, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of sheep special compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

sheep special provided a 1.82% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio1.82%1.70%1.34%1.12%1.12%0.66%0.96%0.97%0.76%0.84%1.09%0.73%
VKTX
Viking Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
4.87%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
NVAX
Novavax, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BNTX
BioNTech SE
0.00%0.00%0.00%0.00%2.43%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
6.07%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%
MRNA
Moderna, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the sheep special. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the sheep special was 59.74%, occurring on Sep 26, 2022. Recovery took 408 trading sessions.

The current sheep special drawdown is 45.55%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-59.74%Aug 10, 2021285Sep 26, 2022408May 10, 2024693
-59.54%Jun 6, 2024212Apr 10, 2025
-30.24%Feb 9, 202119Mar 8, 202163Jun 7, 202182
-28.86%Mar 2, 202011Mar 16, 20202Mar 18, 202013
-27.05%Jul 23, 202033Sep 8, 202057Nov 27, 202090

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 6 assets, with an effective number of assets of 6.00, reflecting the diversification based on asset allocation. This number of effective assets indicates a moderate level of diversification, where some assets may have a more significant influence on overall performance.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

BenchmarkNVOPFEVKTXNVAXBNTXMRNAPortfolio
Benchmark1.000.360.320.370.300.310.310.40
NVO0.361.000.280.270.180.220.200.37
PFE0.320.281.000.190.230.350.310.42
VKTX0.370.270.191.000.280.230.270.55
NVAX0.300.180.230.281.000.410.520.76
BNTX0.310.220.350.230.411.000.560.68
MRNA0.310.200.310.270.520.561.000.71
Portfolio0.400.370.420.550.760.680.711.00
The correlation results are calculated based on daily price changes starting from Oct 11, 2019